MedPath

Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis

Not Applicable
Conditions
Multiple Sclerosis
Interventions
Other: Task Oriented rehabilitation and aerobic training
Registration Number
NCT02960984
Lead Sponsor
Fondazione Don Carlo Gnocchi Onlus
Brief Summary

In Multiple Sclerosis the multiplicity of physical and psychological dysfunctions have been shown to exhibit a number of life-altering problems such as fatigue, limb weakness, alteration of upper extremity fine motor coordination, loss of sensation, spasticity. These problems affect performance of many daily living activities (ADL) such as dressing, bathing, self-care, and writing, thus reducing functional independence and self-rated quality of life.

Twenty people with Multiple Sclerosis will receive neurorehabilitation treatment comprising a combination of aerobic training and upper limb task-oriented training.

The aim of this pilot crossover study is to evaluate the effects of neurorehabilitation on upper limb performance and on fatigue in People with Multiple Sclerosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Diagnosis of Multiple Sclerosis
  • no relapses in the last three months
  • Expanded Disability Status Scale (EDSS) ≤ 8;
Exclusion Criteria
  • subjects with relapses
  • worsening of the pathology in the last three months
  • subjects with cognitive and psychiatric disturbances
  • subjects with cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
NeurorehabilitationTask Oriented rehabilitation and aerobic trainingParticipants in the experimental group will receive 1 hour treatment comprising 30' of aerobic training on an ergometer and 30' of task-oriented training focused on uppper limb rehabilitation.
Primary Outcome Measures
NameTimeMethod
Change from Baseline in Heart Rate at 2 and 4 monthsbaseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Change from Baseline in 9-hole peg test at 2 and 4 monthsbaseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondazione Don Gnocchi ONLUS

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath